Suchergebnisse - "Guan, Xiuwen"

PubPharm (6)

1

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

enthalten in: International journal of cancer | 2020

von Ma, F. | Guan, Y. | Yi, Z. | +16

ErratumIn: Int J Cancer. 2020 Jun 15;146(12):E8. - PMID 32320496

2

Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Guan, X. | Liu, B. | Niu, Y. | +9

3

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients : A Phase I Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Li, Q. | Guan, X. | Chen, S. | +16

4

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

enthalten in: Cancer communications (London, England) | 2019

von Guan, X. | Ma, F. | Li, C. | +13

5

Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition : a proof-of-principle study on the heterogeneity of circulating tumor cells

enthalten in: Oncotarget | 2016

von Guan, X. | Ma, F. | Liu, S. | +7

6

ctDNA dynamics : a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy

enthalten in: Oncotarget | 2016

von Ma, F. | Zhu, W. | Guan, Y. | +9

1
[1]